SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001561743-18-000008
Filing Date
2018-01-17
Accepted
2018-01-18 11:59:51
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 forms-31x17x18.htm S-3 376475
2 INDENTURE s-3exhibit45.htm EX-4.5 383245
3 TG OPINION s-3exhibit51.htm EX-5.1 37691
4 RATIO OF EARNINGS TO FIXED CHARGES s-3exhibit121.htm EX-12.1 50736
5 AUDITOR CONSENT s-3exhibit232.htm EX-23.2 3518
  Complete submission text file 0001561743-18-000008.txt   852631
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222597 | Film No.: 18533414
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1